Switch to
View more

SMS Lifesciences India Ltd

SMSLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹218 cr, stock is ranked 1,644
Moderate RiskStock is 2.85x as volatile as Nifty
715.256.10 (-0.85%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹218 cr, stock is ranked 1,644
Moderate RiskStock is 2.85x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
8.62
PB RatioPB Ratio
1.69
Dividend YieldDiv. Yield
0.21%
Sector PESector PE
32.75
Sector PBSector PB
4.52
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of organic and inorganic chemicals,pharmaceuticals

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022380.36263.06267.37364.5017.8410.1813.5425.30
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.21%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnJun 28, 2022

SMS Lifesciences India Limited has informed the Exchange about Closure of trading window | Download

SMS Lifesciences India Limited has informed the Exchange about Closure of trading window | Download

General updates 
Announced OnJun 24, 2022

SMS Lifesciences India Limited has informed the Exchange that Company¬タルs API¬タルs manufacturing facility located at Sy. No.180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana, has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (US FDA) for the inspection conducted in the month of April, 2022. | Download

SMS Lifesciences India Limited has informed the Exchange that Company¬タルs API¬タルs manufacturing facility located at Sy. No.180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana, has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (US FDA) for the inspection conducted in the month of April, 2022. | Download

Cash Dividend 
Ex. DateSep 20, 2021

Final • Div/Share: ₹ 1.5

See all events